DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

NIIT Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 59 min ago·6 Oct 2026, 5:03 am

Niit

NIIT Limited has received a certificate from the stock market regulator, SEBI, under the Depositories and Participants Regulations. This document confirms that the company has fulfilled all necessary compliance requirements to operate as a Depository Participant, a role that allows it to offer services for holding and transferring securities.

This development is a routine regulatory milestone. For investors, it signifies that NIIT has met the legal standards to facilitate financial transactions, which is a standard expectation for companies in this sector. It does not directly impact the company's core business operations or financial performance at this time.

Investors should monitor the company's future announcements for any specific details regarding the scope of these new services. The focus should remain on the company's operational updates and financial results rather than this regulatory filing alone.